re ONCE: Springboard for many other successful Gene Therapies Spark estimates there are 3,500 people in the United States and five major European countries with these conditions, though the treatment would not be expected to help people whose disease had progressed past a certain point. HOWEVER: “It’s very exciting,” said Gordon Gund, chairman of the Foundation Fighting Blindness, which helped pay for the development of the therapy and some earlier studies of the therapy. He said that while the condition Spark is treating is rare, “this really provides us a platform for many other successful gene therapies.” DO Listen to CC @ 8:30AM EST for further amplification. Your Guide: http://www.sparktx.com/pipeline